Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bioventus (BVS) Cash from Operations (2020 - 2025)

Bioventus' Cash from Operations history spans 6 years, with the latest figure at 37968000.0 for Q4 2025.

  • For Q4 2025, Cash from Operations rose 96.5% year-over-year to 37968000.0; the TTM value through Dec 2025 reached 74673000.0, up 92.48%, while the annual FY2025 figure was 74673000.0, 92.48% up from the prior year.
  • Cash from Operations reached 37968000.0 in Q4 2025 per BVS's latest filing, up from 30098000.0 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 37968000.0 in Q4 2025 to a low of 21019000.0 in Q2 2022.
  • Average Cash from Operations over 5 years is 6913300.0, with a median of 9260500.0 recorded in 2023.
  • Peak YoY movement for Cash from Operations: crashed 776.75% in 2023, then soared 267.85% in 2024.
  • A 5-year view of Cash from Operations shows it stood at 13117000.0 in 2021, then crashed by 60.02% to 5244000.0 in 2022, then skyrocketed by 56.46% to 8205000.0 in 2023, then soared by 135.49% to 19322000.0 in 2024, then surged by 96.5% to 37968000.0 in 2025.
  • Per Business Quant, the three most recent readings for BVS's Cash from Operations are 37968000.0 (Q4 2025), 30098000.0 (Q3 2025), and 25938000.0 (Q2 2025).